こうのうりょうじょうみゃくの英語

動脈の脈動変化量、静脈の脈動変化量、細胞および光学的変化量 等を考慮して、動脈の酸素飽和度を正確に算出する。例文帳に追加

To correctly calculates a saturation degree of blood oxygen in an artery in consideration of the variation of an artery pulse, the variation of a venous pulse, and a cell and optical variation, etc. - 特許庁

この逆濾過によって、高流量静脈膜を通る透析液の著しい流れは、患者の血液中に直接入る。例文帳に追加

That backfiltration causes a significant flow of dialysate through the high flux venous membrane directly into the patient's blood. - 特許庁

この逆濾過によって、高流量静脈膜を通る透析液の著しい流れは、患者の血液中に直接入る。例文帳に追加

That backfiltration causes a significant flow of dialysate through the high flux venous membrane to directly flow into the patient's blood. - 特許庁

治療上有効量の、動脈特異的細胞表面分子と静脈特異的細胞表面分子との結合又は相互作用を変化させる薬物を哺乳動物に投与する工程を含む、哺乳動物の血管形成を変化させる方法。例文帳に追加

A method to alter vascularization of mammals including an administration procedure at a therapeutically effective amount of a medicine altering binding or interaction of artery- and vein-specific cell surface molecules of mammals. - 特許庁

血中脂質濃度抑制剤およびリパーゼ活性の阻害が治療上有効とされる疾患（例えば、肥満症、糖尿病、高血圧症、高脂血症、動脈硬化、面皰）の治療用医薬組成物も提供される。例文帳に追加

The pharmaceutical composition for therapy of a disease for which a suppressor of lipid level in the blood, and the inhibition of the lipase activities are effective for the cure, (e.g. obesity, diabetic, hypertension, hyperlipemia, arteriosclerosis and acne) is also provided. - 特許庁

また、『尊卑分脈』の義経の項目にも「鞍馬寺において、東国旅人諸陵助重頼（頼重）を相語らい、約諾せしめ」と『平治物語』とほぼ同様の記載がある。例文帳に追加

A story similar to "Heiji monogatari" is included in the article about Yoshitsune in "Sonpi Bunmyaku" (a text compiled in the fourteenth century that records the lineages of the aristocracy), which describes that 'Yoshitsune talked with a traveler from Togoku (the eastern part of Japan, particularly Kanto region) named Shoryo no suke Shigeyori (Yorishige) and let him promise to accept his request at Kurama-dera Temple.'発音を聞く  - Wikipedia日英京都関連文書対訳コーパス

卵巣癌治療における化合物 Aの用法又は用量として、本発明の用法又は用量 (脳内の特定部位 Zへの投与)は、従来知られていた用法又は用量 (静脈投与)と相違するので、請求項 1に係る医薬発明は、新規性を有する。例文帳に追加

Regarding dosage and administration of compound A for ovary cancer treatment, dosage and administration (administration to the particular site Z in the human brain) of this invention is different from the already known dosage and administration (intravenous administration). Therefore, the medicinal invention of claim 1 is novel.発音を聞く  - 特許庁